PHARMACOLOGICAL DOSES OF LOVASTATIN DO NOT PREDICTABLY AFFECT THE COURSE OF PSORIASIS

被引：8

作者：

ARONSON, PJ

FRIEDMAN, DB

机构：

来源：

ARCHIVES OF DERMATOLOGY | 1992年 / 128卷 / 01期

关键词：

D O I：

10.1001/archderm.128.1.124

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：124 / 124

页数：1

共 5 条

[1] CYCLOSPORINE IMPROVES PSORIASIS IN A DOUBLE-BLIND-STUDY [J].

ELLIS, CN ;

GORSULOWSKY, DC ;

HAMILTON, TA ;

BILLINGS, JK ;

BROWN, MD ;

HEADINGTON, JT ;

COOPER, KD ;

BAADSGAARD, O ;

DUELL, EA ;

ANNESLEY, TM ;

TURCOTTE, JG ;

VOORHEES, JJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3110-3116

[2]

FEINGOLD KIR, 1991, J INVEST DERMATOL, V96, P1

[3] EXACERBATION OF PSORIASIS BY THE HYPOLIPIDEMIC AGENT, GEMFIBROZIL [J].

FISHER, DA ;

ELIAS, PM ;

LEBOIT, PL .

ARCHIVES OF DERMATOLOGY, 1988, 124 (06) :854-855

[4]

GRUNDY SM, 1988, NEW ENGL J MED, V319, P24

[5] LOW-DENSITY-LIPOPROTEIN RECEPTOR EXPRESSION ON KERATINOCYTES IN NORMAL AND PSORIATIC EPIDERMIS [J].

MOMMAASKIENHUIS, AM ;

GRAYSON, S ;

WIJSMAN, MC ;

VERMEER, BJ ;

ELIAS, PM .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (05) :513-517

← 1 →